1. Home
  2. EVG vs ACOG Comparison

EVG vs ACOG Comparison

Compare EVG & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVG
  • ACOG
  • Stock Information
  • Founded
  • EVG 2005
  • ACOG 2000
  • Country
  • EVG United States
  • ACOG Canada
  • Employees
  • EVG N/A
  • ACOG N/A
  • Industry
  • EVG Investment Managers
  • ACOG
  • Sector
  • EVG Finance
  • ACOG
  • Exchange
  • EVG Nasdaq
  • ACOG Nasdaq
  • Market Cap
  • EVG 148.1M
  • ACOG 149.0M
  • IPO Year
  • EVG N/A
  • ACOG N/A
  • Fundamental
  • Price
  • EVG $11.02
  • ACOG $5.90
  • Analyst Decision
  • EVG
  • ACOG Strong Buy
  • Analyst Count
  • EVG 0
  • ACOG 1
  • Target Price
  • EVG N/A
  • ACOG $18.00
  • AVG Volume (30 Days)
  • EVG 49.4K
  • ACOG 117.7K
  • Earning Date
  • EVG 01-01-0001
  • ACOG 11-13-2025
  • Dividend Yield
  • EVG 8.68%
  • ACOG N/A
  • EPS Growth
  • EVG N/A
  • ACOG N/A
  • EPS
  • EVG N/A
  • ACOG N/A
  • Revenue
  • EVG N/A
  • ACOG $4,586,341.00
  • Revenue This Year
  • EVG N/A
  • ACOG N/A
  • Revenue Next Year
  • EVG N/A
  • ACOG $101.16
  • P/E Ratio
  • EVG N/A
  • ACOG N/A
  • Revenue Growth
  • EVG N/A
  • ACOG N/A
  • 52 Week Low
  • EVG $9.13
  • ACOG $3.75
  • 52 Week High
  • EVG $10.86
  • ACOG $11.54
  • Technical
  • Relative Strength Index (RSI)
  • EVG 41.66
  • ACOG 38.91
  • Support Level
  • EVG $10.97
  • ACOG $5.38
  • Resistance Level
  • EVG $11.24
  • ACOG $6.36
  • Average True Range (ATR)
  • EVG 0.16
  • ACOG 0.58
  • MACD
  • EVG -0.00
  • ACOG 0.05
  • Stochastic Oscillator
  • EVG 27.88
  • ACOG 47.52

About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: